Evidence map›Paper›PMID 25486358›Full record

ArticleCell cycle (Georgetown, Tex.)2014

CD151 represses mammary gland development by maintaining the niches of progenitor cells.

Yuanqin Yin, Xinyu Deng, Zeyi Liu, Lauren A Baldwin, Jason Lefringhouse, Jiayang Zhang, John T Hoff, Sonia F Erfani, Edmund B Rucker, Kathleen O'Connor and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Integrin-associated CD151 is a suppressor of prostate cancer progression.American journal of translational research · 2020
    Article
  4. Article
  5. Article
  6. The Terminal End Bud: the Little Engine that Could.Journal of mammary gland biology and neoplasia · 2017
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Yuanqin Yina Cancer Institute; First Affiliated Hospital ; China Medical University ; Shenyang , China.
Xinyu Deng
Zeyi Liu
Lauren A Baldwin
Jason Lefringhouse
Jiayang Zhang
John T Hoff
Sonia F Erfani
Edmund B Rucker
Kathleen O'Connor
Chunming Liu
Yadi Wu
Binhua P Zhou
Xiuwei H Yang
University of Kentucky · USMarkey Cancer Center · USCancer Institute (WIA) · IN

Funding

Regulation of Snail in breast cancer progression and metastasisR01CA125454 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ZHOU, BINHUA P · 2007 to 2017
$2.8M
Novel Mechanisms of Carcinoma Cell MigrationR01CA109136 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI O'CONNOR, KATHLEEN L. · 2006 to 2016
$2.6M
NCI NIH HHS R01 CA109136NCI NIH HHS R01 CA125454
6 · The paper itself

Abstract

Tetraspanin CD151 interacts with laminin-binding integrins (i.e., α3β1, α6β1 and α6β4) and other cell surface molecules to control diverse cellular and physiological processes, ranging from cell adhesion, migration and survival to tissue architecture and homeostasis. Here, we report a novel role of CD151 in maintaining the branching morphogenesis and activity of progenitor cells during the pubertal development of mammary glands. In contrast to the disruption of laminin-binding integrins, CD151 removal in mice enhanced the tertiary branching in mammary glands by 2.4-fold and the number of terminal end buds (TEBs) by 30%, while having minimal influence on either primary or secondary ductal branching. Consistent with these morphological changes are the skewed distribution of basal/myoepithelial cells and a 3.2-fold increase in proliferating Ki67-positive cells. These novel observations suggest that CD151 impacts the branching morphogenesis of mammary glands by upregulating the activities of bipotent progenitor cells. Indeed, our subsequent analyses indicate that upon CD151 removal the proportion of CD24(Hi)CD49f(Low) progenitor cells in the mammary gland increased by 34%, and their proliferating and differentiating activities were significantly upregulated. Importantly, fibronectin, a pro-branching extracellular matrix (ECM) protein deposited underlying mammary epithelial or progenitor cells, increased by >7.2-fold. Moreover, there was a concomitant increase in the expression and nuclear distribution of Slug, a transcription factor implicated in the maintenance of mammary progenitor cell activities. Taken together, our studies demonstrate that integrin-associated CD151 represses mammary branching morphogenesis by controlling progenitor cell activities, ECM integrity and transcription program.

Indexed as

Stem Cell NicheAnimalsCell DifferentiationCell ProliferationEpithelial CellsExtracellular MatrixFemaleFocal Adhesion Protein-Tyrosine KinasesIntegrinsMammary Glands, AnimalMiceMorphogenesisReceptor Protein-Tyrosine KinasesSignal TransductionSnail Family Transcription FactorsStem CellsCd151 protein, mouseFocal Adhesion Protein-Tyrosine KinasesIntegrinsReceptor Protein-Tyrosine KinasesRON proteinSnai2 protein, mouseSnail Family Transcription FactorsTetraspanin 24Transcription FactorsCD151 tetraspaninECM, extracellular matrixEMT, epithelial-mesenchymal transitionextracellular matrixintegrinLB, laminin-bindingmammary glandSlugTEB, terminal end bud

Identifiers

PMID25486358
PMCPMC4614859
OpenAlexW2125182848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.